LIVN
LivaNova Plc · NASDAQ
- Sector Health Technology
- Industry Medical Specialties
- Website livanova.com
- Employees(FY) 2900
- ISIN GB00BYMT0J19
Performance
+11.95%
1W
+15.7%
1M
+26.11%
3M
+31.39%
6M
+20.62%
YTD
+32.45%
1Y
Profile
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, and markets VNS Therapy System, an implantable device that delivers vagus nerve stimulation (VNS) therapy for the treatment of drug-resistant epilepsy, difficult-to-treat depression, and obstructive sleep apnea. It is also involved in the development and clinical testing of the VITARIA System for treating heart failure through VNS. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. It also engages in research collaboration with Verily to capture clinical biomarkers of depression. LivaNova PLC was founded in 1987 and is headquartered in London, the United Kingdom.
Investment Analysis Report: Livongo Health Inc. (LIVN)
Overview
Livongo Health Inc. (LIVN) operates in the Health Technology sector, specifically in the Medical Specialties industry. The company has a market capitalization of $2.69 billion. In this report, we will conduct a comprehensive analysis of LIVN's financial statements over the past thre...
Technical Analysis of LIVN 2024-05-03
Overview:
In analyzing the technical indicators for LIVN over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive assessment of the stock's potential price movement. By examining these key factors, we aim to offer valuable insights and predictions for the next few days.
Trend Anal...
Recent News & Updates
- 2024-05-03 09:16
- 2024-05-02 11:50
LivaNova PLC (NASDAQ:LIVN) Q1 2024 Earnings Call Transcript(Insider Monkey)
- 2024-05-01 20:12
Analyst Report: LivaNova PLC(Morningstar Research)
- 2024-05-01 09:59
- 2024-05-01 07:33
- 2024-05-01 07:10
- 2024-05-01 06:11
LivaNova: Q1 Earnings Snapshot(Associated Press Finance)
- 2024-05-01 06:00
LivaNova Reports First-Quarter 2024 Results(Business Wire)
- 2024-04-30 19:10
- 2024-04-30 18:00
LivaNova Reports First-Quarter 2024 Results(Businesswire)
- 2024-04-30 09:00
- 2024-04-29 21:00
- 2024-04-26 12:34
Livanova says patient data obtained in 2023 cyberattack(MedTech Dive)
- 2024-04-26 07:21
LivaNova gives notice of personal patient data compromised by hackers(Medical Device Network)
- 2024-04-25 16:03
- 2024-04-25 10:02
- 2024-04-25 04:03
- 2024-04-24 10:01
- 2024-04-23 22:01
- 2024-04-23 20:00
LIVN: Raising target price to $58.00(Argus Research)
- 2024-04-15 15:36
- 2024-03-21 09:00
LivaNova to Announce First-Quarter 2024 Results(Business Wire)
- 2024-03-21 04:46
- 2024-03-20 21:00
LivaNova to Announce First-Quarter 2024 Results(Businesswire)
- 2024-03-20 16:46
- 2024-03-20 09:00
- 2024-03-19 21:00
- 2024-03-19 15:18
- 2024-03-05 21:55
- 2024-03-05 08:55
Page 1 of 6
previousnext